JPRN-UMIN000002947已完成未知
Evaluation of efficacy and safety of riboflavin/UVA treatment for keratoconus/keratectasia - efficacy and safety of riboflavin/UVA for keratoconus
Department of Ophthalmology, Keio University School of Medicine0 个研究点目标入组 30 人开始时间: 2009年12月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 14years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The corneal thickness less than 400 micrometer 2. Those who implanted medical instruments, such as pacemaker. 3. Ocular diseases, such as infection, corneal scar, herpetic keratitis, and/or nystagmus 4. Systemic diseases affecting corneal would healing 5. Eyes with narrow angle. Pregnant or breast-feeding women. 6. Occupation, by which refractive surgery is not arrowed
研究者
相似试验
撤回
不适用
Effects of oral riboflavin supplementation on the growth of Faecalibacterium prausnitzii and the impact on the gut microbiota: A randomized, double-blind, placebo-controlled human intervention trial.Healthy Intestinal MicrobiotaMicrobiota Gut HealthNL-OMON43887DSM Food Specialties105
已完成
不适用
Evaluating the effect of UV-A/Riboflavin Collagen Cross-Linking in treatment of bacterial corneal ulcerCorneal ulcerCorneal ulcers.IRCT2014101919581N1Shiraz Univercity of Medical Seiences
已完成
2 期
Corneal Crosslinking in Patients With Keratoconus and Post-Refractive EctasiaPost-Refractive EctasiaKeratoconusNCT01143389Price Vision Group510
已完成
1 期
Riboflavin and multiple sclerosisMultiple sclerosisMultiple sclerosis.IRCT201102175855N1Ahvaz Jondishapour University of Medical Sciences30
已完成
不适用
Ultraviolet-A and Riboflavin Treatment for Infectious KeratitisInfectious KeratitisNCT01739673Cxlusa13